We are live on
!
Find out more
ACM
ADAR1 Capital Management Portfolio holdings
AUM
$1.7B
1-Year Est. Return
340.85%
This Fund
S&P 500
This Quarter
Est. Return
+8.25%
1 Year Est. Return
+340.85%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.7B
AUM Growth
+$337M
(+25%)
Cap. Flow
+$320M
Cap. Flow
% of AUM
18.81%
Top 10 Holdings %
Top 10 Hldgs %
39.64%
Holding
351
New
78
Increased
102
Reduced
60
Closed
41
Top Buys
| 1 |
Beam Therapeutics
BEAM
|
+$40.1M |
| 2 |
Crinetics Pharmaceuticals
CRNX
|
+$37.1M |
| 3 |
Denali Therapeutics
DNLI
|
+$36.2M |
| 4 |
Inspire Medical Systems
INSP
|
+$27.3M |
| 5 |
Vir Biotechnology
VIR
|
+$21.9M |
Top Sells
| 1 |
RNAM
Avidity Biosciences
RNAM
|
+$39.4M |
| 2 |
RAPT
RAPT Therapeutics
RAPT
|
+$17.3M |
| 3 |
CDTX
Cidara Therapeutics
CDTX
|
+$13.2M |
| 4 |
Fulcrum Therapeutics
FULC
|
+$10.4M |
| 5 |
Arbutus Biopharma
ABUS
|
+$9.98M |
Sector Composition
| 1 | Healthcare | 88.42% |
| 2 | Financials | 1.51% |
| 3 | Technology | 0.08% |
| 4 | Industrials | 0.08% |
| 5 | Materials | 0.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Integer Holdings
ITGR
$3.35B
| $770K | 0.05% |
+8,750
| New | +$745K |
|
177
CALL
Replimune Group
REPL
$798M
| $765K | 0.05% |
100,000
+75,000
| +300% | +$573K |
|
178
Karyopharm Therapeutics
KPTI
$215M
| $762K | 0.04% |
136,736
+86,736
| +173% | +$661K |
|
179
Compass Therapeutics
CMPX
$376M
| $735K | 0.04% |
139,000
| – | – |
|
180
Nuvalent
NUVL
| $711K | 0.04% |
6,942
+100
| +1% | +$10.2K |
|
181
Cullinan Oncology
CGEM
$1.01B
| $711K | 0.04% |
50,000
| – | – |
|
182
IDEAYA Biosciences
IDYA
$3.45B
| $666K | 0.04% |
20,000
| – | – |
|
183
CALL
Fractyl Health
GUTS
$135M
| $654K | 0.04% |
1,428,571
| – | – |
|
184
Enanta Pharmaceuticals
ENTA
$382M
| $649K | 0.04% |
51,357
+10,000
| +24% | +$134K |
|
185
Vera Therapeutics
VERA
$2.84B
| $645K | 0.04% |
16,033
+1,300
| +9% | +$56K |
|
186
VYNE Therapeutics
VYNE
$25.7M
| $636K | 0.04% |
1,063,899
+810,108
| +319% | +$473K |
|
187
Boston Scientific
BSX
$66.2B
| $628K | 0.04% |
10,000
+5,000
| +100% | +$400K |
|
188
Avantor
AVTR
$7.72B
| $627K | 0.04% |
80,000
+10,000
| +14% | +$98.4K |
|
189
Arvinas
ARVN
$517M
| $610K | 0.04% |
57,591
-500
| -0.9% | -$6.19K |
|
|
KZR
190
DELISTED
Kezar Life Sciences
KZR
| $608K | 0.04% |
81,933
-35,507
| -30% | -$231K |
|
|
KLRS
191
Kalaris Therapeutics
KLRS
$111M
| $577K | 0.03% |
100,000
| – | – |
|
192
Mirum Pharmaceuticals
MIRM
$7.14B
| $573K | 0.03% |
+6,200
| New | +$583K |
|
193
Jazz Pharmaceuticals
JAZZ
$15.2B
| $567K | 0.03% |
3,000
-5,000
| -63% | -$874K |
|
194
Assembly Biosciences
ASMB
$510M
| $554K | 0.03% |
19,947
+200
| +1% | +$5.71K |
|
195
Prelude Therapeutics
PRLD
$334M
| $523K | 0.03% |
+152,825
| New | +$401K |
|
|
GTERU
196
Globa Terra Acquisition Corp Units
GTERU
| $518K | 0.03% |
50,000
| – | – |
|
197
WisdomTree Floating Rate Treasury Fund
USFR
$17.9B
| $503K | 0.03% |
10,000
| – | – |
|
198
Aclaris Therapeutics
ACRS
$747M
| $497K | 0.03% |
132,426
-481,560
| -78% | -$1.62M |
|
199
Praxis Precision Medicines
PRAX
$8.62B
| $483K | 0.03% |
1,500
| – | – |
|
200
Pulmonx
LUNG
$60.8M
| $483K | 0.03% |
374,497
+19,087
| +5% | +$31.5K |
|
Similar funds
RSCM
AAM
SGI
WAS
BCM
SWM
TCM
ISS